Pre-emptive administration of fibrinogen concentrate contributes to improved prognosis in patients with severe trauma

…, M Sawano, M Matsuda, M Anan… - Trauma surgery & …, 2016 - tsaco.bmj.com
Background Patients with severe trauma often present with critical coagulopathy, resulting
in impaired hemostasis, massive hemorrhage, and a poor survival prognosis. The efficacy of …

A survey of autologous blood collection and transfusion in Japan in 1997

H Ohto, T Fuji, N Wakimoto, M Anan, H Maeda - Transfusion Science, 2000 - Elsevier
Background: In spite of the fact that autologous blood is safest for a patient to receive, it is
not generally appreciated that adverse reactions during donation and transfusion may occur. …

[HTML][HTML] Producing Iron Endohedral Fullerene on Electron Cyclotron Resonance Ion Source

…, S Harisaki, K Sato, K Tsuda, T Maenaka, M Anan… - Crystals, 2021 - mdpi.com
An electron cyclotron resonance (ECR) ion source (ECRIS) can generate an available
amount of multicharged ions, thus it is not limited for use in the field of accelerator science, but …

Cutoff limitation of left-hand polarization wave and candidates for further enhanced producing multicharged ions on ECRIS

Y Kato, W Kubo, S Harisaki, M Anan… - Journal of Physics …, 2022 - iopscience.iop.org
Based on experimentally obtained plasma parameters in an electron cyclotron resonance (ECR)
ion source (ECRIS) and theoretical considerations, it is turned out the essential factor …

Evaluation of an Improved Blood Warming Device for Transfusion

M Anan, M Okubo, H Maeda - Iryou kikigaku (The Japanese journal …, 2011 - jstage.jst.go.jp
輸血用赤血球製剤は低温 (2~ 6℃) で保管されているため, そのまま輸血すると患者が低体温になる
可能性がある. この副作用を予防するためには, 血液を適切に加温する必要がある. 今回, 安全装置…

[CITATION][C] Scientific evidence and future aspects of fibrinogen concentrate for massive bleeding

…, S MATSUNAGA, M SAWANO, M ANAN… - 日本輸血細胞治療 …, 2017 - jglobal.jst.go.jp
2) Danés AF, Cuenca LG, Bueno SR, et al: Efficacy and tolerability of human fibrinogen
concentrate administration to patients with acquired fibrinogen deficiency and active or in high-…

[CITATION][C] NATIONWIDE QUESTIONNAIRE SURVEY ON TRANSFUSION THERAPY FOR COAGULOPATHY IN MASSIVE HEMORRHAGE IN 2017

M NORO, S UEMATSU, M ANAN, A IMAI… - 日本輸血細胞治療 …, 2019 - jglobal.jst.go.jp
2) 山本晃士, 西脇公俊, 加藤千秋, 他: 術中大量出血を防ぐための新たな輸血治療-クリオプレシピ
テートおよびフィブリノゲン濃縮製剤投与効果の検討-. 日本輸血細胞治療学会誌, 56: 36-42, 2010. 3…

Clinical practice of acute pancreatitis in Japan: an analysis of nationwide epidemiological survey in 2016

…, Y Imamura, H Ohta, N Nishimura, M Shiihara, H Anan… - Pancreatology, 2020 - Elsevier
Background To provide updates on clinical practice of acute pancreatitis (AP) in Japan, we
conducted a nationwide epidemiological survey. Methods This study consisted of a two-…

[CITATION][C] PRE-EMPTIVE ADMINISTRATION OF FIBRINOGEN CONCENTRATE CONTRIBUTES TO IMPROVED PROGMOSIS IN PATIENTS WITH SEVERE …

…, M SAWANO, M MATSUDA, M ANAN… - 日本輸血細胞治療 …, 2017 - jglobal.jst.go.jp
3) Rourke C, Curry N, Khan S, et al: Fibrinogen levels during trauma hemorrhage, response
to replacement therapy, and association with patient outcomes. J Thromb Haemost, 10: 1342…

[CITATION][C] ABO blood group and subtypes

M Okubo, M Anan, M Noro - Nihon rinsho. Japanese Journal of …, 2010 - europepmc.org
[ABO blood group and subtypes]. - Abstract - Europe PMC Sign in | Create an account https://orcid.org
Europe PMC Menu About Tools Developers Help Contact us Helpdesk Feedback Twitter …